References
Price P, Jones T. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? Eur J Cancer 1995; 31A:1924–1927.
Francis DL, Visvikis D, Costa DC, Arulampalam TH, Townsend C, Luthra SK, Taylor I, Ell PJ. Potential impact of [18F]3’-deoxy-d-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging 2003; 30:988–994.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Francis, D.L., Visvikis, D., Costa, D.C. et al. Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET. Eur J Nucl Med Mol Imaging 31, 928 (2004). https://doi.org/10.1007/s00259-003-1438-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-003-1438-0